Abbott India Shares Dip 0.73% Amid Volume Surge; Board Meeting Scheduled

• Abbott India shares declined by 0.73% to Rs 27,280 on Tuesday, experiencing a surge in trading volume.
• The company's board will meet on February 12, 2026, to approve unaudited financial results for Q3 and nine months ending December 31, 2025.
• Annual sales for March 2025 reached Rs 6,409 Crore, with net profit at Rs 1,414 Crore, an increase from the previous year.
• Quarterly sales for September 2025 were Rs 1,757 Crore, and net profit was Rs 415 Crore.
• Abbott India maintains a debt-to-equity ratio of 0.00 as of March 2025, indicating no debt.